BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21997335)

  • 21. Localized form of bronchioloalveolar carcinoma: FDG PET findings.
    Kim BT; Kim Y; Lee KS; Yoon SB; Cheon EM; Kwon OJ; Rhee CH; Han J; Shin MH
    AJR Am J Roentgenol; 1998 Apr; 170(4):935-9. PubMed ID: 9530038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Computer tomography in the diagnosis of peripheral cancer of the lung].
    Lepikhin NM; Perel'man MI; Ternovoi SK
    Klin Med (Mosk); 1984 Apr; 62(4):47-50. PubMed ID: 6330436
    [No Abstract]   [Full Text] [Related]  

  • 24. Noninvasive Computed Tomography-based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial.
    Maldonado F; Duan F; Raghunath SM; Rajagopalan S; Karwoski RA; Garg K; Greco E; Nath H; Robb RA; Bartholmai BJ; Peikert T
    Am J Respir Crit Care Med; 2015 Sep; 192(6):737-44. PubMed ID: 26052977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different efficacy of CT screening for lung cancer according to histological type: analysis of Japanese-smoker cases detected using a low-dose CT screen.
    Kondo R; Yoshida K; Kawakami S; Shiina T; Kurai M; Takasuna K; Yamamoto H; Koizumi T; Honda T; Kubo K
    Lung Cancer; 2011 Dec; 74(3):433-40. PubMed ID: 21663995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indolent, Potentially Inconsequential Lung Cancers in the Pittsburgh Lung Screening Study.
    Thalanayar PM; Altintas N; Weissfeld JL; Fuhrman CR; Wilson DO
    Ann Am Thorac Soc; 2015 Aug; 12(8):1193-6. PubMed ID: 26107281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doubling time calculations for lung cancer by three-dimensional computer-aided volumetry: effects of inter-observer differences and nodule characteristics.
    Koike W; Iwano S; Matsuo K; Kitano M; Kawakami K; Naganawa S
    J Med Imaging Radiat Oncol; 2014 Feb; 58(1):82-8. PubMed ID: 24304703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fractal analysis of internal and peripheral textures of small peripheral bronchogenic carcinomas in thin-section computed tomography: comparison of bronchioloalveolar cell carcinomas with nonbronchioloalveolar cell carcinomas.
    Kido S; Kuriyama K; Higashiyama M; Kasugai T; Kuroda C
    J Comput Assist Tomogr; 2003; 27(1):56-61. PubMed ID: 12544244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of late-phase contrast enhancement on semi-automatic software measurements of CT attenuation and volume of part-solid nodules in lung adenocarcinomas.
    Cohen JG; Goo JM; Yoo RE; Park SB; van Ginneken B; Ferretti GR; Lee CH; Park CM
    Eur J Radiol; 2016 Jun; 85(6):1174-80. PubMed ID: 27161068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective study of volume doubling time in surgically resected non-small cell lung cancer.
    Mackintosh JA; Marshall HM; Yang IA; Bowman RV; Fong KM
    Respirology; 2014 Jul; 19(5):755-62. PubMed ID: 24797504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bronchioloalveolar carcinoma of the lung.
    Bonomo L; Storto ML; Ciccotosto C; Polverosi R; Merlino B; Bellelli M; Guidotti A
    Eur Radiol; 1998; 8(6):996-1001. PubMed ID: 9683709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linear and volume measurements of pulmonary nodules at different CT dose levels - intrascan and interscan analysis.
    Hein PA; Romano VC; Rogalla P; Klessen C; Lembcke A; Dicken V; Bornemann L; Bauknecht HC
    Rofo; 2009 Jan; 181(1):24-31. PubMed ID: 19085687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular profiling of computed tomography screen-detected lung nodules shows multiple malignant features.
    Pajares MJ; Zudaire I; Lozano MD; Agorreta J; Bastarrika G; Torre W; Remírez A; Pio R; Zulueta JJ; Montuenga LM
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):373-80. PubMed ID: 16492931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inter-observer agreement on the morphology of screening-detected lung cancer: beyond pulmonary nodules and masses.
    Rampinelli C; Minotti M; Ancona E; Preda L; Bertolotti R; Summers P; Raimondi S; Bagnardi V; Bellomi M
    Eur Radiol; 2019 Jul; 29(7):3862-3870. PubMed ID: 31062136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspects of bronchioloalveolar carcinoma and of adenocarcinoma with a bronchioloalveolar component: CT findings.
    Torres PP; Capobianco J; Montandon Júnior ME; Meirelles GS
    J Bras Pneumol; 2012; 38(2):218-25. PubMed ID: 22576431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications.
    Lee HY; Lee KS
    J Thorac Imaging; 2011 May; 26(2):106-18. PubMed ID: 21508733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer.
    Kakinuma R; Ohmatsu H; Kaneko M; Kusumoto M; Yoshida J; Nagai K; Nishiwaki Y; Kobayashi T; Tsuchiya R; Nishiyama H; Matsui E; Eguchi K; Moriyama N
    J Comput Assist Tomogr; 2004; 28(1):17-23. PubMed ID: 14716227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Localized pure or mixed ground-glass lung opacities].
    Félix L; Lantuejoul S; Jankowski A; Ferretti G
    J Radiol; 2009 Nov; 90(11 Pt 2):1869-92. PubMed ID: 19953078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
    Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
    Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung cancers diagnosed at annual CT screening: volume doubling times.
    Henschke CI; Yankelevitz DF; Yip R; Reeves AP; Farooqi A; Xu D; Smith JP; Libby DM; Pasmantier MW; Miettinen OS;
    Radiology; 2012 May; 263(2):578-83. PubMed ID: 22454506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.